Europe — EMA
Omidria (Ketorolac, Phenylephrine)
Ketorolac, the active ingredient in Omidria, is a non‑steroidal anti‑inflammatory drug presented as a sterile ophthalmic solution for intra‑operative ocular use.
Request sourcing
What is Ketorolac, Phenylephrine?
Ketorolac, the active ingredient in Omidria, is a non‑steroidal anti‑inflammatory drug presented as a sterile ophthalmic solution for intra‑operative ocular use. It helps control postoperative pain and inflammation following eye surgery, particularly cataract extraction, in adult patients.
GNH USA supplies Omidria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology centres worldwide.
What is Ketorolac, Phenylephrine used for?
Omidria combines ketorolac and phenylephrine to address ocular inflammation and pupil dilation needs during eye surgery. It is indicated for: - Cataract surgery: Provides pain relief and maintains pupil dilation during the procedure. - Intra‑operative ocular inflammation: Reduces post‑operative inflammation after cataract extraction. - Post‑operative pain management in eye surgery: Helps control pain following the procedure.
What are the side effects of Ketorolac, Phenylephrine?
Common Side Effects: - ...
What precautions apply to Ketorolac, Phenylephrine?
Precautions:
What does Ketorolac, Phenylephrine interact with?
Interactions:
